-
Something wrong with this record ?
Complications of Autologous Stem Cell Transplantation in Multiple Myeloma: Results from the CALM Study
A. Waszczuk-Gajda, O. Penack, G. Sbianchi, L. Koster, D. Blaise, P. Reményi, N. Russell, P. Ljungman, M. Trneny, J. Mayer, S. Iacobelli, G. Kobbe, C. Scheid, J. Apperley, C. Touzeau, S. Lenhoff, E. Jantunen, A. Anagnostopoulos, L. Paris, P....
Language English Country Switzerland
Document type Journal Article
NLK
Free Medical Journals
from 2012
PubMed Central
from 2012
Europe PubMed Central
from 2012
ProQuest Central
from 2019-01-01
Open Access Digital Library
from 2012-01-01
Open Access Digital Library
from 2012-01-01
Health & Medicine (ProQuest)
from 2019-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2012
PubMed
35743620
DOI
10.3390/jcm11123541
Knihovny.cz E-resources
- Publication type
- Journal Article MeSH
BACKGROUND: The main goal of this post hoc analysis of the Collaboration to Collect Autologous Transplant Outcomes in Lymphoma and Myeloma (CALM) study was to evaluate the rate of short- and long-term infectious and non-infectious complications occurring after ASCT in patients with multiple myeloma (MM). METHODS: The analysis included all patients with MM from the CALM study who underwent ≥1 ASCT. The primary endpoint of the analysis was to determine the rate of infectious and non-infectious complications after ASCT and to compare them in three time periods: 0-100 days, 101 days-1 year, and >1 year after the first transplant. RESULTS: The analysis included a total of 3552 patients followed up for a median of 56.7 months (range 0.4-108.1). Complication rates decreased with the time from ASCT with 24.85 cases per 100 patient-years from day 0 to 100 days after the transplant, and <2.31 cases per 100 patient-years from the 101st day. At 100 days after ASC T, 45.7% of patients had complications, with infectious events being twice as frequent as non-infectious complications. Bacterial infections (6.5 cases per 100 patient-years, 95% CI: 6.1-7.0) and gastrointestinal complications (4.7 cases per 100 patient-years, 95% CI: 4.3-5.1) were the most common early events. The pattern of complications changed with time from ASCT. The presence of complications after ASCT was not associated with overall survival. CONCLUSIONS: Our data provide a solid basis for comparing ASCT-related complications to those caused by emerging treatments in multiple myeloma, such as CAR T-cell therapy and other immunotherapies.
Belfast City Hospital Belfast BT9 7AB UK
Centre de Recherche Saint Antoine Sorbonne Université INSERM UMR_S 938 75013 Paris France
Charité Universitätsmedizin Berlin 10771 Berlin Germany
CHU de Lille 59000 Lille France
CHU Nantes 44000 Nantes France
Dél Pesti Centrumkórház 1097 Budapest Hungary
Department of Haemato Oncology St Bartholomew's Hospital Barts Health NHS Trust London EC1A 7BE UK
Department of Hematology University Hospitals Leuven 3000 Leuven Belgium
Department of Internal Medicine School of Medicine University of Zagreb 10000 Zagreb Croatia
Department of Pediatric Hematology and Oncology Collegium Medicum UMK 85 067 Bydgoszcz Poland
Division of Hematology Department of Medicine Huddinge Karolinska Institute 171 77 Stockholm Sweden
Division of Hematology SST Papa Giovanni XXIII 24127 Bergamo Italy
Division of Infectious Diseases Department of Health Sciences University of Genoa 16121 Genoa Italy
Division of Infectious Diseases IRC CS Ospedale Policlinico San Martino 16132 Genoa Italy
EBMT Data Office Leiden 2333 AA Leiden The Netherlands
George Papanicolaou General Hospital 57010 Thessaloniki Greece
Heinrich Heine Universitaet 40225 Duesseldorf Germany
Hope Directorate D08 NHY1 Dublin Ireland
Hôpital St Louis 75010 Paris France
Hospital Santa Creu i Sant Pau 08001 Barcelona Spain
Imperial College London SW7 2BX UK
Institut Paoli Calmettes 13009 Marseille France
Nottingham University Nottingham NG7 2QL UK
Radboud University Medical Centre Department of Hematology 6525 GA Nijmegen The Netherlands
Skanes University Hospital 23262 Lund Sweden
Tor Vergata University 00133 Rome Italy
University Hospital 12808 Prague Czech Republic
University Hospital Brno 62500 Brno Czech Republic
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22016957
- 003
- CZ-PrNML
- 005
- 20220720100041.0
- 007
- ta
- 008
- 220718s2022 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/jcm11123541 $2 doi
- 035 __
- $a (PubMed)35743620
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Waszczuk-Gajda, Anna $u Department of Hematology, Transplantation and Internal Medicine, University Clinical Centre-The Medical University of Warsaw, 02-097 Warsaw, Poland $1 https://orcid.org/0000000156261750
- 245 10
- $a Complications of Autologous Stem Cell Transplantation in Multiple Myeloma: Results from the CALM Study / $c A. Waszczuk-Gajda, O. Penack, G. Sbianchi, L. Koster, D. Blaise, P. Reményi, N. Russell, P. Ljungman, M. Trneny, J. Mayer, S. Iacobelli, G. Kobbe, C. Scheid, J. Apperley, C. Touzeau, S. Lenhoff, E. Jantunen, A. Anagnostopoulos, L. Paris, P. Browne, C. Thieblemont, N. Schaap, J. Sierra, I. Yakoub-Agha, L. Garderet, J. Styczynski, H. Schoemans, I. Moiseev, RF. Duarte, Z. Peric, S. Montoto, A. van Biezen, M. Mikulska, M. Aljurf, T. Ruutu, N. Kröger, C. Morris, C. Koenecke, S. Schoenland, GW. Basak
- 520 9_
- $a BACKGROUND: The main goal of this post hoc analysis of the Collaboration to Collect Autologous Transplant Outcomes in Lymphoma and Myeloma (CALM) study was to evaluate the rate of short- and long-term infectious and non-infectious complications occurring after ASCT in patients with multiple myeloma (MM). METHODS: The analysis included all patients with MM from the CALM study who underwent ≥1 ASCT. The primary endpoint of the analysis was to determine the rate of infectious and non-infectious complications after ASCT and to compare them in three time periods: 0-100 days, 101 days-1 year, and >1 year after the first transplant. RESULTS: The analysis included a total of 3552 patients followed up for a median of 56.7 months (range 0.4-108.1). Complication rates decreased with the time from ASCT with 24.85 cases per 100 patient-years from day 0 to 100 days after the transplant, and <2.31 cases per 100 patient-years from the 101st day. At 100 days after ASC T, 45.7% of patients had complications, with infectious events being twice as frequent as non-infectious complications. Bacterial infections (6.5 cases per 100 patient-years, 95% CI: 6.1-7.0) and gastrointestinal complications (4.7 cases per 100 patient-years, 95% CI: 4.3-5.1) were the most common early events. The pattern of complications changed with time from ASCT. The presence of complications after ASCT was not associated with overall survival. CONCLUSIONS: Our data provide a solid basis for comparing ASCT-related complications to those caused by emerging treatments in multiple myeloma, such as CAR T-cell therapy and other immunotherapies.
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Penack, Olaf $u Charité Universitätsmedizin Berlin, 10771 Berlin, Germany
- 700 1_
- $a Sbianchi, Giulia $u Tor Vergata University, 00133 Rome, Italy
- 700 1_
- $a Koster, Linda $u EBMT Data Office Leiden, 2333 AA Leiden, The Netherlands
- 700 1_
- $a Blaise, Didier $u Institut Paoli Calmettes, 13009 Marseille, France
- 700 1_
- $a Reményi, Péter $u Dél-Pesti Centrumkórház, 1097 Budapest, Hungary
- 700 1_
- $a Russell, Nigel $u Nottingham University, Nottingham NG7 2QL, UK
- 700 1_
- $a Ljungman, Per $u Department of Cellular Therapy and Allogeneic Stem Cell Transplantation, Karolinska Comprehensive Cancer Center, Karolinska University Hospital Huddinge, 17177 Stockholm, Sweden $u Division of Hematology, Department of Medicine Huddinge, Karolinska Institute, 171 77 Stockholm, Sweden $1 https://orcid.org/0000000282813245 $7 xx0224650
- 700 1_
- $a Trneny, Marek $u University Hospital, 12808 Prague, Czech Republic $1 https://orcid.org/0000000269526073 $7 nlk20000083659
- 700 1_
- $a Mayer, Jiri $u University Hospital Brno, 62500 Brno, Czech Republic
- 700 1_
- $a Iacobelli, Simona $u Tor Vergata University, 00133 Rome, Italy
- 700 1_
- $a Kobbe, Guido $u Heinrich Heine Universitaet, 40225 Duesseldorf, Germany
- 700 1_
- $a Scheid, Christof $u University of Cologne, 50923 Cologne, Germany
- 700 1_
- $a Apperley, Jane $u Imperial College, London SW7-2BX, UK
- 700 1_
- $a Touzeau, Cyrille $u CHU Nantes, 44000 Nantes, France $1 https://orcid.org/0000000302752575
- 700 1_
- $a Lenhoff, Stig $u Skanes University Hospital, 23262 Lund, Sweden
- 700 1_
- $a Jantunen, Esa $u Department of Medicine, University of Eastern Finland and Hospital District of North Carelia, Kuopio University Hospital, 70211 Kuopio, Finland
- 700 1_
- $a Anagnostopoulos, Achilles $u George Papanicolaou General Hospital, 57010 Thessaloniki, Greece $1 https://orcid.org/0000000343849031
- 700 1_
- $a Paris, Laura $u Division of Hematology, SST Papa Giovanni XXIII, 24127 Bergamo, Italy $1 https://orcid.org/0000000282482343
- 700 1_
- $a Browne, Paul $u Hope Directorate, D08 NHY1 Dublin, Ireland
- 700 1_
- $a Thieblemont, Catherine $u Hôpital St. Louis, 75010 Paris, France
- 700 1_
- $a Schaap, Nicolaas $u Radboud University Medical Centre, Department of Hematology, 6525 GA Nijmegen, The Netherlands
- 700 1_
- $a Sierra, Jorge $u Hospital Santa Creu i Sant Pau, 08001 Barcelona, Spain
- 700 1_
- $a Yakoub-Agha, Ibrahim $u CHU de Lille, 59000 Lille, France $1 https://orcid.org/0000000345248782
- 700 1_
- $a Garderet, Laurent $u Centre de Recherche Saint-Antoine, Sorbonne Université-INSERM, UMR_S 938, 75013 Paris, France $u Département d'Hématologie et de Thérapie Cellulaire, Assistance Publique-Hôpitaux de Paris, Hôpital Pitié Salpetrière, 75012 Paris, France $1 https://orcid.org/0000000261388112
- 700 1_
- $a Styczynski, Jan $u Department of Pediatric Hematology and Oncology, Collegium Medicum UMK, 85-067 Bydgoszcz, Poland $1 https://orcid.org/000000023158119X
- 700 1_
- $a Schoemans, Helene $u Department of Hematology, University Hospitals Leuven, 3000 Leuven, Belgium $u Department of Public Health and Primary Care, ACCENT VV, KU Leuven-University of Leuven, 3000 Leuven, Belgium
- 700 1_
- $a Moiseev, Ivan $u R.M. Gorbacheva Memorial Institute of Hematology, Oncology and Transplantation, Pavlov University, 197022 Saint-Petersburg, Russia
- 700 1_
- $a Duarte, Rafael F $u Hospital Universitario Puerta de Hierro Majadahonda-Universidad Autónoma de Madrid, 28222 Madrid, Spain $1 https://orcid.org/0000000252409815
- 700 1_
- $a Peric, Zinaida $u Department of Internal Medicine, School of Medicine, University of Zagreb, 10000 Zagreb, Croatia
- 700 1_
- $a Montoto, Silvia $u Department of Haemato-Oncology, St Bartholomew's Hospital, Barts Health NHS Trust, London EC1A 7BE, UK $1 https://orcid.org/0000000230069725
- 700 1_
- $a van Biezen, Anja $u EBMT Data Office Leiden, 2333 AA Leiden, The Netherlands
- 700 1_
- $a Mikulska, Malgorzata $u Division of Infectious Diseases, Department of Health Sciences (DISSAL), University of Genoa, 16121 Genoa, Italy $u Division of Infectious Diseases, IRC CS Ospedale Policlinico San Martino, 16132 Genoa, Italy $1 https://orcid.org/0000000255354602
- 700 1_
- $a Aljurf, Mahmoud $u Section of Adult Haematolgy/BMT, King Faisal Specialist Hospital & Research Centre Oncology, Riyadh 11564, Saudi Arabia
- 700 1_
- $a Ruutu, Tapani $u Comprehensive Cancer Center, Department of Hematology, Helsinki University Hospital and University of Helsinki, 00290 Helsinki, Finland $u Clinical Research Institute, Helsinki University Hospital and University of Helsinki, 00280 Helsinki, Finland
- 700 1_
- $a Kröger, Nicolaus $u University Hospital Eppendorf, 20246 Hamburg, Germany
- 700 1_
- $a Morris, Curly $u Belfast City Hospital, Belfast BT9 7AB, UK
- 700 1_
- $a Koenecke, Christian $u Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, 30625 Hannover, Germany
- 700 1_
- $a Schoenland, Stefan $u Department of Internal Medicine V, Division of Hematology/Oncology, Heidelberg University Hospital, 69120 Heidelberg, Germany $1 https://orcid.org/0000000248535579
- 700 1_
- $a Basak, Grzegorz W $u Department of Hematology, Transplantation and Internal Medicine, University Clinical Centre-The Medical University of Warsaw, 02-097 Warsaw, Poland $1 https://orcid.org/0000000338588180
- 773 0_
- $w MED00195462 $t Journal of clinical medicine $x 2077-0383 $g Roč. 11, č. 12 (2022)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35743620 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20220718 $b ABA008
- 991 __
- $a 20220720100036 $b ABA008
- 999 __
- $a ind $b bmc $g 1816384 $s 1168199
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 11 $c 12 $e 20220620 $i 2077-0383 $m Journal of clinical medicine $n J Clin Med $x MED00195462
- LZP __
- $a Pubmed-20220718
